Media Releases back to media release

DNA Money, 23rd September 2009. Ahmedabad

Troikaa Pharma's anaesthetic drug

Ahmedabad-based Troikaa Pharmaceuticals has introduced an anaesthetic dosage, Xynova Endo, a Lidocaine lozenge for customised endoscopy procedures in patients.

Troikaa Pharmaceuticals has introduced a novel anaesthetic drug  Xynova Endo, which is a Lidocaine Lozenge for customised endoscopy procedures for patients. The unique product is useful for anaesthetising a patient's oral cavity or mouth during endoscopic procedures. Xynova Endo is an intra-oral anaesthetic dosage form comprising a Lidocaine Lozenge mounted on a unique holder. The holder allows the patient to suck the lozenge gradually by rolling it in the mouth.

While launching the drug, Ketan Patel, managing director, Troikaa Pharmaceuticals Ltd, said, "The formulation developed for this drug is unique. Lower patient discomfort makes the procedure easier for both the patient and the doctor. At Troikaa, we constantly strive to provide superior therapeutic benefits to improve the patient's conditions."


back to media release